Tag: Andreas Fouras
4DMedical boosts US and Australia expansion with $30M ATM facility
4DMedical announced today that it has secured an At-the-Market (ATM) funding facility with Alpha Investment Partners (AIP) to enhance its capital management program.
4DMedical teams up with Vanderbilt University for burn pit research
Respiratory imaging technology innovator 4DMedical Limited announced today its collaboration with Vanderbilt University Medical Center (VUMC) as part of a research grant awarded by the US Department of Veterans Affairs (VA).
4DMedical partners with Philips to expand US Defence commercialisation
ASX-listed imaging technology developer 4DMedical Limited has signed a teaming agreement with Koninklijke Philips, a leading global healthcare company, to commercialise 4D Medical’s XV Technology within the US Department of Veterans Affairs.
4DMedical expands with Imbio acquisition and successful equity raise
Respiratory imaging technology company 4DMedical Limited has officially inked a binding agreement for the acquisition of Imbio, a pioneering US-based medical technology company.
Philips, 4DMedical ink MoU to boost respiratory imaging solutions for veterans
Respiratory imaging technology company 4DMedical Limited has entered into a Memorandum of Understanding (MoU) with global healthcare company Koninklijke Philips to broaden federal and commercial sales opportunities for XV Technology in North America.
4DMedical expands lung imaging tech with SaaS deals in Detroit and Memphis
Respiratory imaging technology company 4DMedical Limited has officially inked agreements to provide XV LVAS scans at imaging facilities within the Detroit and Memphis communities.
4DMedical gets US FDA green light clearance for CT-based ventilation product
Respiratory imaging technology company 4DMedical Limited announced the receipt of clearance from the US Food and Drug Administration (FDA) for its CT-based ventilation product CT LVAS.
4DMedical receives gov’t funding to further develop lung scanner tech
Australian respiratory imaging tech company 4DMedical Limited has secured $1.1 million in funding from the Clinical Translation and Commercialisation Medtech (CTCM) program, an initiative of the Medical Research Future Fund delivered by MTPConnect.
4DMedical reveals progress in CT-based ventilation-perfusion product
Medical equipment manufacturing company 4DMedical Limited said it has made material progress in the development of its CT-based ventilation-perfusion product (CT:VQ), which quantifies and visualises regional ventilation and regional perfusion.
4DMedical completes $20m placement for respiratory imaging platform commercialisation
Respiratory imaging technology company 4DMedical Limited has completed a share placement worth $20 million to accelerate the commercialisation of its four-dimensional respiratory imaging platform.
Featured Article
The future of sports manufacturing: Inside M2M Group’s AI-powered strategy
As the sports manufacturing industry evolves, artificial intelligence (AI) is emerging as a critical catalyst for innovation and efficiency.
